Li Auto Inc vs Sanofi SA — how do they compare? Li Auto Inc trades at $12.36 (market cap $12.43B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 8.4× Li Auto Inc's market cap, and Sanofi SA pays a 5.5% dividend while Li Auto Inc pays none. Which is the better fit depends on your goals.
| LI | SNY | |
|---|---|---|
Market Cap | $12.43B | $104.83B |
Sector | Consumer Cyclical | Health |
52-Week High | $30.84 | $52.34 |
52-Week Low | $11.74 | $41.33 |
Enterprise Value | $1.34B | $121.32B |
Dividend Yield | — | 5.5% |
Trailing returns across standard periods
Latest headlines on both assets
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →